Target intelligence / Profile preview

Immunoglobulin lambda variable 5-37 (IGLV5-37)

Target
IGLV5-37
Molecular classification
Immunoglobulin variable domain, Immunoglobulin light chain variable region, Other
01

Overview

Immunoglobulin lambda variable 5-37 (IGLV5-37) encodes the variable (V) region of the lambda light chain in human immunoglobulins[1][2][4][7]. The variable region is assembled by V-(D)-J rearrangement and is critical for antigen binding specificity as part of the antibody structure[1][2][3][7]. This gene product represents only the variable domain of immunoglobulin light chains and, on its own, is not considered a direct therapeutic target, receptor, enzyme, or signaling molecule but rather a component within the overall immunoglobulin (antibody) complex that mediates adaptive immune recognition[1][2][4][7]. Note: - This entry specifically describes an antibody gene segment and not a receptor, transporter, or typical druggable protein target. - No approved drugs are known to interact directly with this gene segment, and it is not currently used as a clinical biomarker or direct disease target. - While immunoglobulin gene rearrangements and expressions are central to immune-related diseases, mutations or aberrations in IGLV5-37 itself are not commonly cited as standalone disease mechanisms or direct therapeutic targets.

Other names
IGLV5-37IGLV537V4-1
02

Biological functions

Antigen recognitionImmune response
03

Disease associations

Other

Beyond the preview

Go deeper on Immunoglobulin lambda variable 5-37 (IGLV5-37).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin lambda variable 5-37 (IGLV5-37).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call